Amicus Therapeutics competitors
Amicus Therapeutics's competitors include Mast Therapeutics, Zogenix, Clinigen Group and BTG
Add company...
You can compare up to 12 companies. Please remove a company to add a new one
| Save ComparisonClear all |  Amicus Therapeutics Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases. |  Zogenix Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology. |  Clinigen Group A specialty pharmaceutical and services company with a unique business model dedicated to delivering the right drug to the right patient at the right time | ||
Founding Date | Founding Date 2002 | Founding Date 1995 | Founding Date 2006 | Founding Date 2010 | Founding Date 1948 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Cranbury Township, US HQ Puteaux, FR Munich, DE Amsterdam, NL Denham, GB | Locations San Diego, US HQ | Locations Emeryville, US HQ Maidenhead, GB San Diego, US | Locations Burton upon Trent, GB HQ | Locations London, GB HQ Rosedale, AU Ottawa, CA Alzenau, DE Hong Kong, HK Neihu District, TW Brentwood, US see more |
Employees | Employees 263 | Employees 14133% increase | Employees 67 | Employees 465200% increase | Employees 1,355 |
Valuation ($) | Valuation ($) 3.1 b | Valuation ($) 403.5 m | Valuation ($) 1.6 b | Valuation ($) 1.8 b | Valuation ($) 3.9 b |
Twitter followers | Twitter followers 793 | Twitter followers 873 | Twitter followers 475 | Twitter followers 1.2 k | Twitter followers 786 |
Financial ⚠ | |||||
Revenue (est.) | Revenue (est.) $36.9m (FY, 2017) | Revenue (est.) N/A | Revenue (est.) $9.8m (FY, 2017) | Revenue (est.) £302.3m (FY, 2017) | Revenue (est.) £570.5m (FY, 2017) |
Cost of goods | Cost of goods $6.2m (FY, 2017) | Cost of goods N/A | Cost of goods $10.7m (FY, 2017) | Cost of goods £179.6m (FY, 2017) | Cost of goods £179.9m (FY, 2017) |
Gross profit | Gross profit $30.7m (FY, 2017) | Gross profit N/A | Gross profit ($908k) (FY, 2017) | Gross profit £122.7m (FY, 2017) | Gross profit £390.6m (FY, 2017) |
Net income | Net income N/A | Net income ($29.8m) (FY, 2017) | Net income ($126.8m) (FY, 2017) | Net income £3.8m (FY, 2017) | Net income £33.6m (FY, 2017) |
For sources of this data, please see the company profileDownload Excel
View company profiles
Zogenix
HQ
Emeryville, US
Employees
67
Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology.
View companyClinigen Group
HQ
Burton upon Trent, GB
Employees
465
A specialty pharmaceutical and services company with a unique business model dedicated to delivering the right drug to the right patient at the right time
View company